Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: A randomized, double-blind, placebo-controlled trial

Published:2015-01 Issue:1 Volume:157 Page:64-71
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Park Soo Yeun^ORCID,Choi Gyu-Seog^ORCID,Park Jun Seok^ORCID,Kim Hye Jin^ORCID,Park Ju-A^ORCID,Choi Jong Ik^ORCID

Publisher

Elsevier BV

Subject

Surgery

Reference29 articles.

1. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997;Heald;Arch Surg,1998

2. Cooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands;Kapiteijn;Br J Surg,2002

3. Potency, cure, and local control in the operative treatment of rectal cancer;Enker;Arch Surg,1992

4. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer;Hendren;Ann Surg,2005

5. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery;Maurer;Br J Surg,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Neoadjuvant Therapy on the Functional Outcome of Patients With Rectal Cancer: A Systematic Review and Meta-Analysis;Clinical Oncology;2023-02

2. Preparation and characterization of morphine gelatine microspheres;Designed Monomers and Polymers;2022-12-20

3. Male erectile function after treatment for colorectal cancer: a population‐based cross‐sectional study;Colorectal Disease;2021-02

4. Phosphodiesterases 5 Inhibitors and Erectile Dysfunction Recovery after Pelvic Surgery: Future Perspectives for New Drugs and New Formulations;Current Drug Targets;2020-12-31

5. Overview of Cancer Survivorship Care for Primary Care Providers;Cureus;2020-09-02